Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Aortic valvuloplasty Stories

2012-10-26 00:32:15

Results of PARTNER Cohort B trial presented at TCT 2012 A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery. Results of the PARTNER Cohort B trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the...

2012-08-15 14:21:24

LOS ANGELES, Aug. 15, 2012 /PRNewswire-USNewswire/ -- UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place August 9th. Ronald Reagan UCLA Medical Center is part of a growing trend of hospitals nationwide offering this new minimally invasive procedure. As the U.S. population ages, an...

2012-05-15 06:29:21

NATICK, Mass., May 15, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus(TM) Aortic Valve System in patients with severe aortic valve disease. The Lotus Aortic Valve System is the first transcatheter aortic valve replacement (TAVR) device of its kind that is designed to minimize aortic regurgitation (leaking) and is both fully repositionable and retrievable prior to release....

2012-01-24 14:10:00

AUSTIN, Texas, Jan. 24, 2012 /PRNewswire/ -- On January 24, Heart Hospital of Austin opened a Heart Valve Clinic, the first of its kind in the region. The clinic gives new hope to patients with severe aortic stenosis who were previously considered "inoperable," delivering a multidisciplinary approach to evaluating such cases. Additionally, interventional cardiologists and cardiac surgeons at the clinic will collaboratively identify patients who may be eligible for a new,...

2011-11-11 01:50:34

2-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy A two-year study of patients in the landmark PARTNER trial, which compared transcatheter aortic valve replacement (TAVR) in patients who have severe aortic stenosis and are not candidates for open heart surgery, confirm the one-year findings and support the role of TAVR as the standard of care. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular...

2011-11-02 16:17:00

SILVER SPRING, Md., Nov. 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Senile aortic valve stenosis is a progressive, age-related disease caused by calcium deposits on the aortic valve that cause the valve to narrow. As the heart works harder to...

2011-10-03 15:21:42

University Hospitals Case Medical Center physician-scientists participate in new multidisciplinary program and clinical trial Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, they cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD, of University Hospitals (UH) Case Medical in Cleveland. "If it isn't functioning properly, there is less blood flow to the...

2011-09-30 13:05:00

CLEVELAND, Sep. 30, 2011 /PRNewswire/ -- Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD, of University Hospitals (UH) Case Medical in Cleveland. "If it isn't functioning properly, there is less blood flow to the body and patients may experience fatigue, fainting, stroke, poor kidney function and heart...

2011-06-24 23:06:56

 An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery. "This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and...

2011-06-06 15:43:56

Results published in today's New England Journal of Medicine Less invasive catheter-based aortic valve replacement and open valve-replacement surgery have a similar one-year survival for patients at high risk for surgery. Results from The PARTNER (Placement of AoRTic traNscathetER valves) Trial "” the world's first randomized clinical trial of a transcatheter aortic heart valve "” were published today in the New England Journal of Medicine. The findings were also presented on June...